Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Chronic Heart Failure

  Free Subscription

Articles published in J Cardiol

Retrieve available abstracts of 73 articles:
HTML format

Single Articles

    November 2021
  1. YAMASHITA M, Kamiya K, Hamazaki N, Nozaki K, et al
    Work status before admission relates to prognosis in older patients with heart failure partly through social frailty.
    J Cardiol. 2021 Nov 21. pii: S0914-5087(21)00307.
    PubMed     Abstract available

  2. NAKAO Y, Kawakami H, Saito M, Inoue K, et al
    Cost-Effectiveness of long-term tolvaptan administration for chronic heart failure treatment in Japan.
    J Cardiol. 2021 Nov 16. pii: S0914-5087(21)00287.
    PubMed     Abstract available

  3. TSAI YL, Chou RH, Lu YW, Chang CC, et al
    Associations between galectin-1, left ventricular diastolic dysfunction, and heart failure with preserved ejection fraction.
    J Cardiol. 2021 Nov 10. pii: S0914-5087(21)00258.
    PubMed     Abstract available

    October 2021
  4. OKADA M, Inoue K
    Catheter ablation of atrial fibrillation with left ventricular systolic dysfunction: Potential approach to the cause of heart failure-authors' reply.
    J Cardiol. 2021;78:347-348.

    September 2021
  5. IWAHASHI N, Kirigaya J, Abe T, Horii M, et al
    Clinical usefulness of left ventricular outflow tract velocity time integral for heart failure with reduced ejection fraction with rapid atrial fibrillation during landiolol treatment.
    J Cardiol. 2021 Sep 23. pii: S0914-5087(21)00242.
    PubMed     Abstract available

    August 2021
  6. KONISHI M, Akiyama E, Shibata A, Kida K, et al
    Moderate potassium lowering effect of exogenous atrial natriuretic peptide in patients with acute heart failure.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00197.
    PubMed     Abstract available

  7. KANAI M, Yagishita D, Shoda M, Ejima K, et al
    Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00195.
    PubMed     Abstract available

    June 2021
  8. YAMADA T, Haruki S, Minami Y, Numata M, et al
    The C-reactive protein to prealbumin ratio on admission and its relationship with outcome in patients hospitalized for acute heart failure.
    J Cardiol. 2021 Jun 10. pii: S0914-5087(21)00131.
    PubMed     Abstract available

  9. YANAGIHARA K, Kinugasa Y, Kunimi T, Kaneko S, et al
    Child ego state and self-care behavior change in heart failure patients.
    J Cardiol. 2021 Jun 2. pii: S0914-5087(21)00128.
    PubMed     Abstract available

  10. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    PubMed     Abstract available

  11. TOMII D, Horiuchi Y, Gonda Y, Yoshiura D, et al
    The role of the renal resistance index in patients with heart failure with reduced or preserved ejection fraction.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00130.
    PubMed     Abstract available

    May 2021
  12. TSAI YN, Cheng WH, Chang YT, Hsiao YW, et al
    Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmia.
    J Cardiol. 2021 May 28. pii: S0914-5087(21)00108.
    PubMed     Abstract available

  13. HITOMI Y, Nagatomo Y, Yukino M, Yumita Y, et al
    Characterization of tolvaptan response and its impact on the outcome for patients with heart failure.
    J Cardiol. 2021 May 23. pii: S0914-5087(21)00111.
    PubMed     Abstract available

    April 2021
  14. MARUYAMA M, Yasuoka R, Nagano T, Nakazawa G, et al
    Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study.
    J Cardiol. 2021 Apr 30. pii: S0914-5087(21)00091.
    PubMed     Abstract available

  15. NAKAMURA T, Tsujita K
    Current trends and future perspectives for heart failure treatment leveraging cGMP modifiers and the practical effector PKG.
    J Cardiol. 2021 Apr 1. pii: S0914-5087(21)00059.
    PubMed     Abstract available

  16. NAKAJIMA DOI S, Seguchi O, Yamamoto M, Fujita T, et al
    Impact of bridge-to-bridge strategies from paracorporeal to implantable left ventricular assist devices on the pre-heart transplant outcome: A single-center analysis of 134 cases.
    J Cardiol. 2021;77:408-416.
    PubMed     Abstract available

    March 2021
  17. YOKOYAMA H, Shishido K, Tobita K, Moriyama N, et al
    Impact of age on mid-term clinical outcomes and left ventricular reverse remodeling after cardiac resynchronization therapy.
    J Cardiol. 2021;77:254-262.
    PubMed     Abstract available

  18. DAYANAND S, Martinez JM, Figueredo VM, Gupta S, et al
    Mechanical Circulatory Support in Women.
    J Cardiol. 2021;77:209-216.
    PubMed     Abstract available

    February 2021
  19. MAEMURA K, Ikeda Y, Oki T, Yazaki M, et al
    Clinical significance of ischemia-like electrocardiographic finding during heart failure treatment on left ventricular recovery in patients with non-ischemic dilated cardiomyopathy.
    J Cardiol. 2021 Feb 19. pii: S0914-5087(21)00037.
    PubMed     Abstract available

  20. KIKUCHI A, Taniguchi T, Nakamoto K, Sera F, et al
    Feasibility of home-based cardiac rehabilitation using an integrated telerehabilitation platform in elderly patients with heart failure: A pilot study.
    J Cardiol. 2021 Feb 10. pii: S0914-5087(21)00023.
    PubMed     Abstract available

  21. SOEDA T, Okura H, Saito Y, Nakao K, et al
    Clinical characteristics and in-hospital outcomes in patients aged 80 years or over with cardiac troponin-positive acute myocardial infarction -J-MINUET study.
    J Cardiol. 2021;77:139-146.
    PubMed     Abstract available

  22. NAITO Y, Masuyama T, Ishihara M
    Iron and cardiovascular diseases.
    J Cardiol. 2021;77:160-165.
    PubMed     Abstract available

    January 2021
  23. FUJIMOTO W, Konishi A, Iwasaki M, Toh R, et al
    Precipitating factors and clinical impact of early rehospitalization for heart failure in patients with heart failure in Awaji Island, Japan.
    J Cardiol. 2021 Jan 5. pii: S0914-5087(20)30418.
    PubMed     Abstract available

  24. SHIINA Y, Nagao M, Shimomiya Y, Inai K, et al
    Secondary sarcopenia assessed by computed tomography can predict hospitalization for heart failure in adults with Fontan circulation.
    J Cardiol. 2021;77:10-16.
    PubMed     Abstract available

  25. KANAMORI H, Naruse G, Yoshida A, Minatoguchi S, et al
    Morphological characteristics in diabetic cardiomyopathy associated with autophagy.
    J Cardiol. 2021;77:30-40.
    PubMed     Abstract available

    December 2020
  26. TANAKA H, Yamauchi Y, Imanishi J, Hatani Y, et al
    Effect of ivabradine on left ventricular diastolic function of patients with heart failure with preserved ejection fraction -IVA-PEF study.
    J Cardiol. 2020 Dec 31. pii: S0914-5087(20)30417.
    PubMed     Abstract available

  27. NATANZON SS, Mazin I
    Author's reply: The outcome of acute decompensated heart failure stratified by the Norton scale on admission.
    J Cardiol. 2020 Dec 4. pii: S0914-5087(20)30385.

  28. IZUMIDA T, Imamura T
    The outcome of acute decompensated heart failure stratified by the Norton scale on admission.
    J Cardiol. 2020 Dec 3. pii: S0914-5087(20)30386.

  29. IZUMIDA T, Imamura T
    Sarcopenia in patients with cardiovascular disease.
    J Cardiol. 2020;76:636.

    November 2020
  30. KURODA S, Mizukami A, Hiroki J, Shimizu Y, et al
    Clinical impact of serial change in brain natriuretic peptide before and after catheter ablation in patients with atrial fibrillation and heart failure.
    J Cardiol. 2020 Nov 25. pii: S0914-5087(20)30374.
    PubMed     Abstract available

  31. CHANG WT, Lin CH, Hong CS, Liao CT, et al
    The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction.
    J Cardiol. 2020 Nov 21. pii: S0914-5087(20)30359.
    PubMed     Abstract available

  32. HATA R, Kato T, Yaku H, Morimoto T, et al
    Implantable Cardioverter Defibrillator Therapy in Patients with Acute Decompensated Heart Failure with Reduced Ejection Fraction: An Observation from the KCHF Registry.
    J Cardiol. 2020 Nov 12. pii: S0914-5087(20)30339.
    PubMed     Abstract available

    October 2020
  33. MIRO O, Lopez-Diez MP, Rossello X, Gil V, et al
    Analysis of standards of quality for outcomes in acute heart failure patients directly discharged home from emergency departments and their relationship with the emergency department direct discharge rate.
    J Cardiol. 2020 Oct 11. pii: S0914-5087(20)30307.
    PubMed     Abstract available

    September 2020
  34. KIMURA M, Kohno T, Sawano M, Heidenreich PA, et al
    Independent and cumulative association of clinical and morphological heart failure with long-term outcome after percutaneous coronary intervention.
    J Cardiol. 2020 Sep 1. pii: S0914-5087(20)30208.
    PubMed     Abstract available

  35. KOBAYASHI S, Yoshiga Y, Yano M
    Author's reply: The RyR2 - Targeting therapy against lethal arrhythmia.
    J Cardiol. 2020;76:323-324.

    August 2020
  36. KWAK S, Kwon S, Lee SY, Yang S, et al
    Differential risk of incident cancer in patients with heart failure: A nationwide population-based cohort study.
    J Cardiol. 2020 Aug 28. pii: S0914-5087(20)30271.
    PubMed     Abstract available

  37. MIZOBUCHI A, Osawa K, Tanaka M, Yumoto A, et al
    Detrended fluctuation analysis can detect the impairment of heart rate regulation in patients with heart failure with preserved ejection fraction.
    J Cardiol. 2020 Aug 18. pii: S0914-5087(20)30274.
    PubMed     Abstract available

  38. TOPAZ G, Yehezkel E, Benchetrit S, Korzets Z, et al
    Non-coronary cardiac calcifications and outcomes in patients with heart failure.
    J Cardiol. 2020 Aug 18. pii: S0914-5087(20)30261.
    PubMed     Abstract available

  39. NAKANE E, Kato T, Tanaka N, Kuriyama T, et al
    Association of the induction of a self-care management system with 1-year outcomes in patients hospitalized for heart failure.
    J Cardiol. 2020 Aug 2. pii: S0914-5087(20)30257.
    PubMed     Abstract available

    July 2020
  40. CAFFREY JL, Wu CK, Chang CH, Lin JW, et al
    Analysis of mortality risk following receipt of implantable cardioverter defibrillators in patients with and without heart failure.
    J Cardiol. 2020 Jul 15. pii: S0914-5087(20)30184.
    PubMed     Abstract available

  41. PHAM VT, Lin C, Tran TT, M Su MY, et al
    Predicting ventricular tachyarrhythmia in patients with systolic heart failure based on texture features of the gray zone from contrast-enhanced magnetic resonance imaging.
    J Cardiol. 2020 Jul 13. pii: S0914-5087(20)30222.
    PubMed     Abstract available

  42. TAKAGI K, Sato N, Ishihara S, Iha H, et al
    Differences in pharmacological property between combined therapy of the vasopressin V2-receptor antagonist tolvaptan plus furosemide and monotherapy of furosemide in patients with hospitalized heart failure.
    J Cardiol. 2020 Jul 11. pii: S0914-5087(20)30172.
    PubMed     Abstract available

  43. MITANI H, Funakubo M, Sato N, Murayama H, et al
    In-hospital resource utilization, worsening heart failure, and factors associated with length of hospital stay in patients with hospitalized heart failure: A Japanese database cohort study.
    J Cardiol. 2020 Jul 4. pii: S0914-5087(20)30173.
    PubMed     Abstract available

  44. SAITO H, Yamashita M, Endo Y, Mizukami A, et al
    Cognitive impairment measured by Mini-Cog provides additive prognostic information in elderly patients with heart failure.
    J Cardiol. 2020 Jul 2. pii: S0914-5087(20)30210.
    PubMed     Abstract available

    June 2020
  45. NATANZON SS, Maor E, Klempfner R, Goldenberg I, et al
    Norton score and clinical outcomes following acute decompensated heart failure hospitalization.
    J Cardiol. 2020 Jun 10. pii: S0914-5087(20)30178.
    PubMed     Abstract available

    May 2020
  46. HARADA D, Asanoi H, Noto T, Takagawa J, et al
    The impact of right ventricular dysfunction on the effectiveness of beta-blockers in heart failure with preserved ejection fraction.
    J Cardiol. 2020 May 28. pii: S0914-5087(20)30163.
    PubMed     Abstract available

  47. SATO K, Takahashi J, Hao K, Miyata S, et al
    Temporal trends in the prevalence and outcomes of geriatric patients with acute myocardial infarction in Japan-A report from the Miyagi AMI Registry Study.
    J Cardiol. 2020;75:465-472.
    PubMed     Abstract available

    April 2020
  48. NAKAGAWA Y, Kuwahara K
    Sodium-Glucose Cotransporter-2 inhibitors are potential therapeutic agents for treatment of non-diabetic heart failure patients.
    J Cardiol. 2020 Apr 24. pii: S0914-5087(20)30122.
    PubMed     Abstract available

  49. SPARTALIS M, Iliopoulos DC, Spartalis E, Athanasiou A, et al
    The genesis of ventricular arrhythmias in heart failure patients is based on alterations in cardiac mechanical, morphological, metabolic, electrophysiological properties, and neurohumoral remodeling.
    J Cardiol. 2020 Apr 22. pii: S0914-5087(20)30104.

  50. YAMAMOTO S, Yamaga T, Nishie K, Sakai Y, et al
    Impact of physical performance on prognosis among patients with heart failure: Systematic review and meta-analysis.
    J Cardiol. 2020 Apr 11. pii: S0914-5087(20)30094.
    PubMed     Abstract available

  51. TAKAGI K, Ishihara S, Kenji N, Iha H, et al
    Clinical significance of arterial stiffness as a factor for hospitalization of heart failure with preserved left ventricular ejection fraction: a retrospective matched case-control study.
    J Cardiol. 2020 Apr 5. pii: S0914-5087(20)30069.
    PubMed     Abstract available

  52. KODZISZEWSKA K, Sochanowicz B, Smigielski W, Kruszewski M, et al
    Grey areas and open questions in neprilysin inhibition.
    J Cardiol. 2020;75:462-463.

  53. CHANG HY, Yin WH
    Response to "Grey Areas and Open Questions in Neprilysin Inhibition".
    J Cardiol. 2020;75:463-464.

  54. LIANG Y, Wang J, Yu Z, Zhang M, et al
    Comparison between cardiac resynchronization therapy with and without defibrillator on long-term mortality: A propensity score matched analysis.
    J Cardiol. 2020;75:432-438.
    PubMed     Abstract available

    March 2020
  55. SUZUKI A, Shiga T, Kawashiro N, Hagiwara N, et al
    Changes in characteristics and outcomes in Japanese patients with heart failure from the 2000s to the 2010s: The HIJ-HF cohorts.
    J Cardiol. 2020 Mar 18. pii: S0914-5087(20)30064.
    PubMed     Abstract available

  56. CHANG HY, Chen KC, Fong MC, Feng AN, et al
    Recovery of left ventricular dysfunction after sacubitril/valsartan: predictors and management.
    J Cardiol. 2020;75:233-241.
    PubMed     Abstract available

    February 2020
  57. SPARTALIS M, Iliopoulos DC, Spartalis E, Athanasiou A, et al
    Is the clinical benefit of implantable cardioverter-defibrillators in heart failure patients declining?
    J Cardiol. 2020 Feb 27. pii: S0914-5087(20)30045.

  58. DISERTORI M, Mase M, Rigoni M, Nollo G, et al
    Author's reply: "Declining clinical benefit of ICD in heart failure patients".
    J Cardiol. 2020 Feb 22. pii: S0914-5087(20)30038.

  59. NISTRI S, Mazzone C, Cioffi G, Barbati G, et al
    Tissue Doppler indices of diastolic function as prognosticator in patients without heart failure in primary care.
    J Cardiol. 2020 Feb 21. pii: S0914-5087(20)30034.
    PubMed     Abstract available

  60. KAWAGUCHI J, Hamatani Y, Hirayama A, Nishimura K, et al
    Experience of morphine therapy for refractory dyspnea as palliative care in advanced heart failure patients.
    J Cardiol. 2020 Feb 12. pii: S0914-5087(20)30016.
    PubMed     Abstract available

    January 2020
  61. NAKANO I, Tsuda M, Kinugawa S, Fukushima A, et al
    Loop diuretic use is associated with skeletal muscle wasting in patients with heart failure.
    J Cardiol. 2020 Jan 27. pii: S0914-5087(20)30018.
    PubMed     Abstract available

  62. HIRAIWA H, Okumura T, Kondo T, Kato T, et al
    Usefulness of the plasma branched-chain amino acid/aromatic amino acid ratio for predicting future cardiac events in patients with heart failure.
    J Cardiol. 2020 Jan 27. pii: S0914-5087(20)30017.
    PubMed     Abstract available

    December 2019
  63. NOZAKI K, Hamazaki N, Kamiya K, Ichikawa T, et al
    Rising time from bed in acute phase after hospitalization predicts frailty at hospital discharge in patients with acute heart failure.
    J Cardiol. 2019 Dec 30. pii: S0914-5087(19)30381.
    PubMed     Abstract available

  64. KAGIYAMA Y, Yatsuga S, Kinoshita M, Koteda Y, et al
    Growth differentiation factor 15 as a useful biomarker of heart failure in young patients with unrepaired congenital heart disease of left to right shunt.
    J Cardiol. 2019 Dec 26. pii: S0914-5087(19)30382.
    PubMed     Abstract available

  65. KOBAYASHI S, Wakeyama T, Ono S, Ikeda Y, et al
    A multicenter, randomized, double-blind, controlled study to evaluate the efficacy and safety of dantrolene on ventricular arrhythmia as well as mortality and morbidity in patients with chronic heart failure (SHO-IN trial): rationale and design.
    J Cardiol. 2019 Dec 19. pii: S0914-5087(19)30282.
    PubMed     Abstract available

    November 2019
    The critical roles of protein quality control systems in the pathogenesis of heart failure.
    J Cardiol. 2019 Nov 4. pii: S0914-5087(19)30318.
    PubMed     Abstract available

    October 2019
  67. KONISHI M, Matsuzawa Y, Ebina T, Kosuge M, et al
    Impact of population density on mortality in patients hospitalized for heart failure - JROAD-DPC Registry Analysis.
    J Cardiol. 2019 Oct 9. pii: S0914-5087(19)30298.
    PubMed     Abstract available

    September 2019
  68. HAYASHI H, Abe Y, Morita Y, Yamaji Y, et al
    Prognostic significance of moderate primary mitral regurgitation and concomitant paroxysmal atrial fibrillation.
    J Cardiol. 2019 Sep 12. pii: S0914-5087(19)30276.
    PubMed     Abstract available

  69. YAMASAKI H, Sekiguchi Y, Gosho M, Nogami A, et al
    Design and results of aCRT MID-Q study: Adoption of adaptive CRT in patients with normal AV conduction and moderately wide left bundle branch block.
    J Cardiol. 2019 Sep 3. pii: S0914-5087(19)30262.
    PubMed     Abstract available

    May 2019
  70. GOURRONC Y, Grall S, Ingremeau D, Desprets L, et al
    De novo atrial fibrillation as an independent prognostic marker after ST-segment elevation myocardial infarction: Results from the RIMA registry.
    J Cardiol. 2019 May 9. pii: S0914-5087(19)30040.
    PubMed     Abstract available

  71. NAKASHIMA A, Miyoshi T, Aoki-Kamiya C, Nishio M, et al
    Predicting postpartum cardiac events in pregnant women with complete atrioventricular block.
    J Cardiol. 2019 May 3. pii: S0914-5087(19)30099.
    PubMed     Abstract available

    April 2019
  72. FERRI-CERTIC J, Zavrl-Dzananovic D, Lezaic L, Zizek D, et al
    Impact of left ventricular pacing threshold on ventricular arrhythmia occurrence in cardiac resynchronization therapy.
    J Cardiol. 2019 Apr 13. pii: S0914-5087(19)30087.
    PubMed     Abstract available

    February 2019
    Author's reply.
    J Cardiol. 2019;73:186.

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.